VAPO Vapotherm, Inc.

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals through a direct sales force in the United States; and through distributors in various countries internationally. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

$22.00  +0.88 (4.17%)
As of 11/30/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  11/14/2018
Outstanding shares:  26,072,567
Average volume:  163,293
Market cap:   $547,523,907
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    922107107
ISIN:        US9221071072
Sedol:      BGYBYK8
Valuation   (See tab for details)
PE ratio:   -9.43
PB ratio:   6.69
PS ratio:   4.15
Return on equity:   -50.17%
Net income %:   -31.27%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy